Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress

Ähnliche Einträge

• Plasma lipoprotein Lp(a), markers of hemostasis and inflammation and risk of coronary heart disease
  Veröffentlicht: (2003)
• Lipoprotein associated phospholipase A2 concentration predicts total and cardiovascular mortality independently of established risk factors (The Ludwigshafen risk and cardiovascular health study)
  von: Kleber, Marcus E., et al.
  Veröffentlicht: (2011)
• Renal hemodynamics
  von: Fliser, Danilo, et al.
  Veröffentlicht: (1996)
• Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies
  von: König, Wolfgang, et al.
  Veröffentlicht: (2010)
• Relationship between markers of inflammation and hemodynamic stress and death in patients with out-of-hospital cardiac arrest
  von: Zelniker, Thomas, et al.
  Veröffentlicht: (2021)